Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Prostate cancer
Closed
Phase 3
This study is looking at using apalutamide to slow down the growth of prostate cancer.
It is open to men whose early prostate cancer is being managed by active surveillance. And who have a higher risk of their cancer getting worse.
Recruitment start: 24 April 2023
Recruitment end: 28 February 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Vincent Gnanapragasam
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge
Last reviewed: 27 Feb 2026
CRUK internal database number: 18021
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
